The New Stack CMS Built While You Weren't Looking
CMS has unveiled a coordinated payment architecture that expands beyond traditional fee‑for‑service, launching the ACCESS model with over 150 approved participants slated to begin July 5. The model pays Medicare beneficiaries directly for outcome‑aligned chronic disease management, featuring consumer brands like Noom, Weight Watchers, and WHOOP alongside large ACO platforms. Complementary initiatives such as MAHA ELEVATE, TEMPO, and the upcoming LEAD ACO model create a stack of prevention‑focused programs, collectively representing billions in potential payment flows. Private insurers covering 165 million lives have already pledged to align with these new payment structures, signaling a systemic shift toward a “System B+” prevention economy.
What Your Wearable Knows That Your Doctor Ignores: Weekly Livestream W/ Brooks Leitner
The Food is Health newsletter is hosting a live stream on April 17 at 2 p.m. ET with Dr. Brooks Leitner, a Yale‑trained physician‑scientist and co‑founder of VO Health. The discussion will focus on VO2 max, a fitness metric that research shows...
Weeks 5-7 of AI Agent Corner: From an Experiment to a Team
The AI Agent Corner series chronicles how Ellen Brown’s agent Uni and Carter Williams’s agent Wilson evolved from experimental tools to a multi‑room operational team. Over weeks 5‑7 the duo tackled five simultaneous channels, exposing pain points such as context...
Weekly FIH Livestream | Inside the CPG Machine - A 30-Year Veteran on Why the Outcomes Layer Doesn't Exist Yet
WiseCode is building the world’s most comprehensive, real‑time food attribute database, linking product scans to DNA, blood work and long‑term eating patterns. Its Scout app lets consumers add new items in seconds, creating a continuously expanding data set. The company’s...
MAHA ELEVATE Part II: Should You Apply? And If Yes, Where Do You Actually Start?
CMS has launched the MAHA ELEVATE $100 million cooperative agreement, inviting up to 30 organizations to run randomized, evidence‑generating lifestyle and functional‑medicine trials in the Original Medicare population. A non‑binding Letter of Intent is due by April 10 5 pm ET, with full applications required by...